drugset / Trial / NCT04140903

Partial Oral Antibiotic Treatment for Bacterial Brain Abscess

NCT04140903 ↗

Phase 4 Recruiting 400 enrolled Henrik Nielsen
RandomizedParallel-groupSingle-blindTreatment

Summary

The investigators aim to determine if oral antibiotics are clinically acceptable as treatment of brain abscess. Following 2 weeks of standard intravenous antibiotic therapy, half of patients will continue with this treatment for another 4 weeks or longer while the other half will be assigned to oral antibiotics for the remaining duration of treatment.

Timeline

Start
2020-11-06
Primary completion
2028-08-31
Completion
2028-08-31

Drugs

EvaluationDrugModalityDoseRoute
Background Amoxicillin Other / unclassified — Oral
Background Metronidazole Small molecule — Oral

Indications